Acquiring Company
Mankind Pharma
Acquired Company
Bharat Serums and Vaccines Limited
Description
Mankind Pharma will take control of Bharat Serums and Vaccines Limited's business through a voluntary liquidation process. This acquisition is valued at Rs 13,768 crore and aims at integrating BSVL's operations efficiently. The decision to pursue this method avoids the lengthy NCLT approval process normally required for mergers. The restructuring aims to enhance operational efficiency and resource utilization for Mankind Pharma.
Don't miss Mankind Pharma's next move
Get an email the moment Mankind Pharma makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Bharat Serums and Vaccines Limited?
Bharat Serums and Vaccines Limited was acquired by Mankind Pharma, based in New Delhi. The deal was reported on September 13, 2026. Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. Mankind Pharma is privately held and operates in Biotechnology.
When did Mankind Pharma acquire Bharat Serums and Vaccines Limited?
Mankind Pharma's acquisition of Bharat Serums and Vaccines Limited was reported on September 13, 2026. Mankind Pharma will take control of Bharat Serums and Vaccines Limited's business through a voluntary liquidation process. This acquisition is valued at Rs 13,768 crore and aims at integrating BSVL's operations efficiently. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bharat Serums and Vaccines Limited do?
Bharat Serums and Vaccines Limited (BSV) is a wholly owned subsidiary specializing in vaccines and biopharmaceuticals. The company works towards the development and manufacture of a range of healthcare products. It is privately held, operating in Pharmaceutical, and is based in Navi Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.